{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T04:40:34Z","timestamp":1699677634964},"reference-count":22,"publisher":"Medical Association of Nippon Medical School","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2023,10,25]]},"DOI":"10.1272\/jnms.jnms.2023_90-605","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T22:23:05Z","timestamp":1666304585000},"page":"419-424","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Course and Cytokine Profile of Systemic Juvenile Idiopathic Arthritis in a Patient with Trisomy 21"],"prefix":"10.1272","volume":"90","author":[{"given":"Yujiro","family":"Tanabe","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuya","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanae","family":"Tsuno","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Yamanishi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Narazaki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Fukazawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Shimizu M, Yokoyama T, Yamada K, et al. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford) [Internet]. 2010 Sep;49 (9):1645-53. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20472718 Epub 2010 May 14.","DOI":"10.1093\/rheumatology\/keq133"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Avau A, Put K, Wouters CH, Matthys P. Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis. Cytokine Growth Factor Rev [Internet]. 2015 Feb;26 (1):35-45. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24948570 Epub 2014 May 24.","DOI":"10.1016\/j.cytogfr.2014.05.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Shigemura T, Yamazaki T, Hara Y, et al. Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome. Pediatr Rheumatol Online J [Internet]. 2011 Jul 13;9 (1):15. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21749729","DOI":"10.1186\/1546-0096-9-15"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Xia Y, Cui P, Li Q, Liang F, Li C, Yang J. Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases. Braz J Med Biol Res [Internet]. 2017 Feb 16;50 (2):e5958. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28225869","DOI":"10.1590\/1414-431x20165958"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yasin S, Fall N, Brown RA, et al. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome. Rheumatology (Oxford) [Internet]. 2020 Feb 1;59 (2):361-6. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31326996","DOI":"10.1093\/rheumatology\/kez282"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yokoyama T, Shimizu M, Ikeno I, et al. Case of systemic-onset juvenile idiopathic arthritis complicated with sepsis--usefulness of cytokine profile for the differentiation between macrophage activation syndrome and sepsis. Nihon Rinsho Meneki Gakkai Kaishi [Internet]. 2011;34 (2):105-11. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21628853 English, Japanese.","DOI":"10.2177\/jsci.34.105"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Prada N, Nasi M, Troiano L, et al. Direct analysis of thymic function in children with Down&apos;s syndrome. Immun Ageing [Internet]. 2005;2:4. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15715912","DOI":"10.1186\/1742-4933-2-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kyritsi EM, Kanaka-Gantenbein C. Autoimmune thyroid disease in specific genetic syndromes in childhood and adolescence. Front Endocrinol (Lausanne) [Internet]. 2020;11:543. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32973676","DOI":"10.3389\/fendo.2020.00543"},{"key":"9","unstructured":"9. Aso S, Imada Y, Kawasaki T, Yanagawa H. [Nationwide survey on the association of Kawasaki disease and Down syndrome]. Tokyo: Kawasaki disease study group supported by Ministry of Health, Labour and Welfare; 1987."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Jones JT, Smith C, Becker ML, Lovell D, CARRA Registry Investigators.  Down syndrome-associated arthritis cohort in the new childhood arthritis and rheumatology research alliance registry: clinical characteristics, treatment, and outcomes. Arthritis Care Res (Hoboken) [Internet]. 2021 Dec;73 (12):1739-45. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33242376","DOI":"10.1002\/acr.24418"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nicek A, Talib N, Lovell D, Smith C, Becker ML, Jones JT. Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists. Pediatr Rheumatol Online J [Internet]. 2020 Jul 13;18 (1):57. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32660497","DOI":"10.1186\/s12969-020-00445-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Peeters M, Poon A. Down syndrome and leukemia: unusual clinical aspects and unexpected methotrexate sensitivity. Eur J Pediatr [Internet]. 1987 Jul;146 (4):416-22. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2958283","DOI":"10.1007\/BF00444952"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Buitenkamp TD, Mathot RA, de Haas V, Pieters R, Zwaan CM. Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia. Haematologica [Internet]. 2010 Jul;95 (7):1106-13. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20418240 Epub 2010 Apr 23.","DOI":"10.3324\/haematol.2009.019778"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shimizu M, Nakagishi Y, Yachie A. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine [Internet]. 2013 Feb;61 (2):345-8. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23276493 Epub 2012 Dec 29.","DOI":"10.1016\/j.cyto.2012.11.025"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mizuta M, Shimizu M, Inoue N, Nakagishi Y, Yachie A. Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome. Cytokine [Internet]. 2019 Jul;119:182-7. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30952065 Epub 2019 Apr 2.","DOI":"10.1016\/j.cyto.2019.03.018"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shimizu M. Macrophage activation syndrome in systemic juvenile idiopathic arthritis. Immunol Med [Internet]. 2021 Dec;44 (4):237-45. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33982649 Epub 2021 May 13.","DOI":"10.1080\/25785826.2021.1912893"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mizuta M, Shimizu M, Inoue N, et al. Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis. Rheumatology (Oxford) [Internet]. 2021 May 14;60 (5):2421-6. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33200207","DOI":"10.1093\/rheumatology\/keaa634"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kusters MA, Verstegen RH, Gemen EF, de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol [Internet]. 2009 May;156 (2):189-93. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19250275 Epub 2009 Jan 22.","DOI":"10.1111\/j.1365-2249.2009.03890.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Verstegen RHJ, Driessen GJ, Bartol SJW, et al. Defective B-cell memory in patients with Down syndrome. J Allergy Clin Immunol [Internet]. 2014 Dec;134 (6):1346-53.e9. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25159464","DOI":"10.1016\/j.jaci.2014.07.015"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kusters MA, Gemen EF, Verstegen RH, Wever PC, DE Vries E. Both normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T lymphocytes. Pediatr Res [Internet]. 2010 May;67 (5):557-62. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20098345","DOI":"10.1203\/PDR.0b013e3181d4eca3"},{"key":"21","unstructured":"21. Ravelli A, Minoia F, Davi S, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol [Internet]. 2016 Mar;68 (3):566-76. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26314788 Epub 2016 Feb 9."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Saper VE, Chen G, Deutsch GH, et al. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis [Internet]. 2019 Dec;78 (12):1722-31. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31562126 Epub 2019 Sep 27. Erratum in: Ann Rheum Dis. 2022 Feb;81 (2): e35.","DOI":"10.1136\/annrheumdis-2019-216040corr1"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/90\/5\/90_JNMS.2023_90-605\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T04:04:45Z","timestamp":1699675485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/90\/5\/90_JNMS.2023_90-605\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2023_90-605","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"article-number":"JNMS.2023_90-605"}}